Moreover, the combination of PF-03084014 and fludarabine is able to reduce angiogenesis and CXCL12-induced responses in NOTCH1-mutated CLL cells, in particular those related to tumor migration and invasion [11]. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.